Format

Send to

Choose Destination
Cutis. 2007 Jun;79(6):430-4.

Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.

Author information

1
Valley Hospital Medical Center, Las Vegas, Nevada, USA.

Abstract

Oral trimethoprim/sulfamethoxazole (TMP-SMX) is approved by the US Food and Drug Administration for the treatment of urinary tract infections, shigellosis, acute otitis media in pediatric patients, and Pneumocystis carinii pneumonia. TMP-SMX has been used off label in dermatology to treat various skin conditions, including acne vulgaris and other skin and soft tissue infections, especially those infections caused by methicillin-resistant Staphylococcus aureus.

PMID:
17713145
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center